ALNYLAM PHARMACEUTICALS, INC. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Alnylam Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Alnylam Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $28.9M, a 37.7% decline year-over-year.
  • Alnylam Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $172M, a 59.6% decline from 2022.
  • Alnylam Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $426M, a 65.9% decline from 2021.
  • Alnylam Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $1.25B, a 25.3% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $172M -$254M -59.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 $426M -$821M -65.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $1.25B +$252M +25.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $995M +$172M +20.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $823M +$758M +1157% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-10
2018 $65.5M -$1.06B -94.2% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-11
2017 $1.12B +$947M +533% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-13
2016 $178M Jan 1, 2016 Dec 31, 2016 10-K 2019-02-14
2013 $201M +$108M +115% Jan 1, 2013 Dec 31, 2013 10-K 2014-02-20
2012 $93.4M +$92.7M +12557% Jan 1, 2012 Dec 31, 2012 10-K 2014-02-20
2011 $738K -$2.93M -79.9% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-20
2010 $3.66M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.